The Effective Statistician - in association with PSI

Discussion on the highlights of 2023, plans for webinars and new content in 2024, introduction of a statistics talk show, leadership training and data visualization, and the new Change Agent program.

Oliver Keene, a statistician, discusses the evolving landscape of estimands. They cover topics such as estimates for repeated continuous outcomes, treatment policy, intent-to-treat analysis, communication challenges, and the validity of last observation analysis.

Explore the new FDA DSUR reporting requirement and its impact. Learn about the expanded scope of the safety summary regulation. Understand the importance of comprehensive planning and ongoing safety assessments. Find out how to implement an effective safety process in companies. Connect with Greg for further assistance.

Benjamin, an expert in statistical trends, joins Alexander to discuss the rise of large language models, transparency in data and privacy concerns, virtual and augmented reality in work environments, collaboration through specialized marketplaces, open source programming and collaboration, and payer involvement in drug development. This thought-provoking episode explores the dynamic trends shaping the statistical landscape and emphasizes the importance of staying informed and embracing new approaches in effective statistical work in drug development.

In this podcast, the speaker discusses the importance of networking, training, and engaging in impactful projects for creating opportunities in a statistical career. They highlight the role of external collaborations, conferences, and special interest groups for expanding networks. The speaker also emphasizes the significance of preparation, confidence-building, and investing in leadership skills. Overall, they encourage statisticians to actively create opportunities and be proactive in their career growth.

Artemis Koukounari, an expert in observational studies and Estimand frameworks, discusses the challenges and experiences of using Estimands in observational studies. Topics include enhancing controls with historical data, challenges with propensity score methods, importance of sensitivity analysis, and differences between clinical trials and observational studies

Interview with Mirjam Sandlos, an exploration of belief systems and strategies for personal and professional growth. Topics include: concept of 'Glaubenssatz', power of thoughts on actions and outcomes, breaking limiting beliefs, impact on career, and the importance of embracing a growth mindset.

Importance of clear long-term vision and goals in personal and professional life; breaking down goals for increased trust and influence; setting visible and meaningful goals for alignment and action; identifying key capabilities and setting achievable goals; setting challenging and motivating goals

Learn about the trajectory of R in the industry and the growth of AstraZeneca's R community. Discover the activities that contributed to its success, metrics for measuring its impact, and the personal journey of Guillaume Desachy in building the community. Explore the dynamics of collaboration among R enthusiasts at AstraZeneca and gain valuable learnings from their experiences.

In this episode, Alexander Schacht discusses the pitfalls of bad strategy and the elements of a good strategy. He shares strategic insights from historical examples and emphasizes the importance of clear diagnosis, guiding principles, and tactical planning. The episode also explores the significance of strategy in decision-making, personal growth, and business success. It further highlights the power of podcasting as a tool for strategic thinking and collaboration.